Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases

Journal of Biochemistry

Volumn 151, Issue 3, 2012, Pages 291-298

  Park, Ji Yoon ^a   Park, Jun Hyoung ^a   Jang, Wookju ^b   Hwang, In Kwan ^a   Kim, In Ja ^c   Kim, Hwa Jung ^c   Cho, Kyung Hyun ^b   Lee, Seung Taek ^a  

^a Yonsei University   (South Korea)

^b Yeungnam University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

anti oxidant activity; apolipoprotein A IV (ApoA IV); lipid metabolism; matrix metalloproteinase (MMP); substrate

Indexed keywords

APOLIPOPROTEIN A4; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; ENZYME MECHANISM; ENZYME SUBSTRATE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; PATHOGENESIS; PLASMA; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PURIFICATION; PROTEOMICS;

APOLIPOPROTEINS A; HUMANS; LIPID METABOLISM; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASES;

EID: 84863257557     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr137     Document Type: Article

References (40)

1. Van Lint, P. and Libert, C. (2007) Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 82, 1375-13812.
2. Morancho, A., Rosell, A., Garcia-Bonilla, L., and Montaner, J. (2010) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann. N. Y. Acad. Sci. 1207, 123-133
3. Burke, B. (2004) The role of matrix metalloproteinase 7 in innate immunity. Immunobiology 209, 51-56 (Pubitemid 39255691)
4. Zhang, S.C. and Kern, M. (2009) The role of host-derived dentinal matrix metalloproteinases in reducing dentin bonding of resin adhesives. Int. J. Oral. Sci. 1, 163-176
5. Spinale, F.G. (2002) Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90, 520-530 (Pubitemid 34640901)
6. Skrzydlewska, E., Sulkowska, M., Koda, M., and Sulkowski, S. (2005) Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11, 1251-1266 (Pubitemid 40425906)
7. Swaney, J.B., Reese, H., and Eder, H.A. (1974) Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem. Biophys. Res. Commun. 59, 513-519
8. Green, P.H., Glickman, R.M., Riley, J.W., and Quinet, E. (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest. 65, 911-919 (Pubitemid 10144067)
9. Weinberg, R.B., Ibdah, J.A., and Phillips, M.C. (1992) Adsorption of apolipoprotein A-IV to phospholipids monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins. J. Biol. Chem. 267, 8977-8983
10. Tubb, M.R., Silva, R.A., Fang, J., Tso, P., and Davidson, W.S. (2008) A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry. J. Biol. Chem. 283, 17314-17323
11. Dieplinger, H., Ankerst, D.P., Burges, A., Lenhard, M., Lingenhel, A., Fineder, L., Buchner, H., and Stieber, P. (2009) Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 18, 1127-1133
12. Hayashi, H., Nutting, D.F., Fujimoto, K., Cardelli, J.A., Black, D., and Tso, P. (1990) Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31, 1613-1625
13. Steinmetz, A. and Utermann, G. (1985) Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260, 2258-2264 (Pubitemid 15105725)
14. Main, L.A., Ohnishi, T., and Yokoyama, S. (1996) Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV. Biochim. Biophys. Acta 1300, 17-24 (Pubitemid 26103895)
15. Goldberg, I.J., Scheraldi, C.A., Yacoub, L.K., Saxena, U., and Bisgaier, C.L. (1990) Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265, 4266-4272
16. Ostos, M.A., Conconi, M., Vergnes, L., Baroukh, N., Ribalta, J., Girona, J., Caillaud, J.M., Ochoa, A., and Zakin, M.M. (2001) Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1023-1028 (Pubitemid 34168663)
17. Ferretti, G., Bacchetti, T., Bicchiega, V., and Curatola, G. (2002) Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem. Phys. Lipids 114, 45-54 (Pubitemid 34158766)
18. Hwang, I.K., Park, S.M., Kim, S.Y., and Lee, S.T. (2004) A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim. Biophys. Acta 1702, 79-87 (Pubitemid 39265471)
19. Tubb, M.R., Smith, L.E., and Davidson, W.S. (2009) Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease. J. Lipid Res. 50, 1497-1504
20. Koo, H.M., Kim, J.H., Hwang, I.K., Lee, S.J., Kim, T.H., Rhee, K.H., and Lee, S.T. (2002) Refolding of the catalytic and hinge domains of human MT1-MMP expressed in Escherichia coli and its characterization. Mol. Cells 13, 118-124 (Pubitemid 41583057)
21. Kim, S.Y., Park, S.M., and Lee, S.T. (2006) Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. Biochem. Biophys. Res. Commun. 339, 47-54 (Pubitemid 41697512)
22. Park, J.H., Park, S.M., Park, K.H., Cho, K.H., and Lee, S.T. (2011) Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14. Biochem. Biophys. Res. Commun. 409, 58-63
23. Jo, Y., Yoon, D.-W., Kim, M.Y., Lee, Y.J., Kim, H.J., and Lee, S.T. (1999) Tissue inhibitor of metalloproteinases-2 inhibits the 4-aminophenylmercuric acetate-induced activation and autodegradation of the free promatrix metalloproteinase-2. J. Biochem. Mol. Biol. 32, 60-66 (Pubitemid 129628823)
24. Park, S.M., Hwang, I.K., Kim, S.Y., Lee, S.J., Park, K.S., and Lee, S.T. (2006) Characterization of plasma gelsolin as a substrate for matrix metalloproteinases. Proteomics 6, 1192-1199
25. Park, J.H., Park, S.M., Park, S.H., Cho, K.H., and Lee, S.T. (2008) Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. Proteomics 8, 2926-2935
26. Cho, K.H., Park, S.H., Han, J.M., Kim, H.C., Choi, Y.K., and Choi, I. (2006) ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities. Eur. J. Clin. Invest. 36, 875-882 (Pubitemid 44707087)
27. Benzie, I.F. and Strain, J.J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239, 70-76
28. Park, K.H., Shin, D.G., Kim, J.R., and Cho, K.H. (2010) Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. J. Gerontol. A Biol. Sci. Med. Sci. 65, 600-610
29. Qin, X., Swertfeger, D.K., Zheng, S., Hui, D.Y., and Tso, P. (1998) Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. 274, H1836-H1840
30. Wong, W.M., Gerry, A.B., Putt, W., Roberts, J.L., Weinberg, R.B., Humphries, S.E., Leake, D.S., and Talmud, P.J. (2007) Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192, 266-274 (Pubitemid 46726327)
31. Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., and Shinomura, Y. (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp. Biol. Med. (Maywood) 231, 20-27 (Pubitemid 43063974)
32. Yu, W.H., Woessner, J.F. Jr., McNeish, J.D., and Stamenkovic, I. (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307-323 (Pubitemid 34111411)
33. Vargo-Gogola, T., Crawford, H.C., Fingleton, B., and Matrisian, L.M. (2002) Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch. Biochem. Biophys. 408, 155-161 (Pubitemid 36027034)
34. Davies, G., Jiang, W.G., and Mason, M.D. (2001) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 7, 3289-3297 (Pubitemid 32963856)
35. Pearson, K., Tubb, M.R., Tanaka, M., Zhang, X.Q., Tso, P., Weinberg, R.B., and Davidson, W.S. (2005) Specific sequences in the N and C termini of apolipoprotein A-IV modulate its conformation and lipid association. J. Biol. Chem. 280, 38576-38582 (Pubitemid 43853758)
36. Tubb, M.R., Silva, R.A., Pearson, K.J., Tso, P., Liu, M., and Davidson, W.S. (2007) Modulation of apolipoprotein A-IV lipid binding by an interaction between the N and C termini. J. Biol. Chem. 282, 28385-28394 (Pubitemid 47606038)
37. Turk, B.E., Huang, L.L., Piro, E.T., and Cantley, L.C. (2001) Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667 (Pubitemid 32625438)
38. Dallinga-Thie, G.M., van Tol, A., van't Hooft, F.M., and Groot, P.H. (1986) Distribution of apolipoproteins A-I and A-IV among lipoprotein classes in rat mesenteric lymph, fractionated by molecular sieve chromatography. Biochim. Biophys. Acta 876, 108-115 (Pubitemid 16011004)
39. Katsuda, S. and Kaji, T. (2003) Atherosclerosis and extracellular matrix. J. Atheroscler. Thromb. 10, 267-274
40. Williams, H., Johnson, J.L., Jackson, C.L., White, S.J., and George, S.J. (2010) MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc. Res. 87, 137-146